Cardiovascular effects of antifibrinolytic drugs.
D031841:Aconitum / Q000633:toxicity; D000614:Aminocaproates / Q000008:administration & dosage / Q000494:pharmacology; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology; D000933:Antifibrinolytic Agents / Q000494:pharmacology*; D007611:Aprotinin / Q000008:administration & dosage / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002297:Cardanolides / Q000633:toxicity; D002319:Cardiovascular System / Q000187:drug effects*; D002415:Cats; D002712:Chlorides / Q000633:toxicity; D003326:Coronary Circulation / Q000187:drug effects; D003509:Cyclohexanecarboxylic Acids / Q000008:administration & dosage / Q000494:pharmacology; D004285:Dogs; D004562:Electrocardiography; D005260:Female; D006168:Guinea Pigs; D006329:Heart Conduction System / Q000187:drug effects; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D008274:Magnesium / Q000633:toxicity; D008744:Methylamines / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012119:Respiration / Q000187:drug effects; D012849:Sinoatrial Node / Q000187:drug effects; D013997:Time Factors; D014599:Uterus / Q000187:drug effects; D014630:Vagus Nerve / Q000187:drug effects
D000614:Aminocaproates; D000889:Anti-Arrhythmia Agents; D000933:Antifibrinolytic Agents; D002297:Cardanolides; D002712:Chlorides; D003509:Cyclohexanecarboxylic Acids; D008744:Methylamines; D007611:Aprotinin; D008274:Magnesium